{"id":590,"date":"2020-10-20T17:53:34","date_gmt":"2020-10-20T15:53:34","guid":{"rendered":"https:\/\/limnopharma.com\/en\/?p=590"},"modified":"2021-01-20T17:54:29","modified_gmt":"2021-01-20T16:54:29","slug":"limnopharma-signs-a-research-agreement-with-fundacion-progreso-y-salud-for-the-execution-of-the-lead-retina-research-project","status":"publish","type":"post","link":"https:\/\/limnopharma.com\/en\/blog\/2020\/10\/20\/limnopharma-signs-a-research-agreement-with-fundacion-progreso-y-salud-for-the-execution-of-the-lead-retina-research-project\/","title":{"rendered":"Limnopharma signs a research agreement with \u201cFundaci\u00f3n Progreso y Salud\u201d for the execution of the \u201cLead Retina\u201d research project"},"content":{"rendered":"<p>Limnopharma signs a Research Agreement with \u201cFundaci\u00f3n Progreso y Salud\u201d, an organization which belongs to the Andalusian Region Ministry of Health (Spain).<\/p>\n<p>The agreement includes the execution of the \u201cLead retina\u201d research project, led by Dr. Dr. D\u00edaz-Corrales, to analyze the efficacy and safety of our lead drug targeting Retinitis Pigmentosa (RP). The Project includes the assay, using a mouse model for RP (RD-10 mice) of a series of polyphenolic compounds, Limnopharma\u2019s own technology, to select the best candidate as treatment for RP.<\/p>\n<p>This agreement constitutes a step forward in our collaboration with FPS, employer of our co-founder, DR. D\u00edaz-Corrales, and owner of one of the patents exclusively licensed by Limnopharma. Let\u2019s hope a fruitful collaboration for years to come!<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Limnopharma signs a Research Agreement with \u201cFundaci\u00f3n Progreso y Salud\u201d, an organization which belongs to the Andalusian Region Ministry of Health (Spain). The agreement includes the execution of the \u201cLead retina\u201d research project, led by Dr. Dr. D\u00edaz-Corrales, to analyze the efficacy and safety of our lead drug targeting Retinitis Pigmentosa (RP). The Project includes [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":406,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":""},"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/limnopharma.com\/en\/wp-json\/wp\/v2\/posts\/590"}],"collection":[{"href":"https:\/\/limnopharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/limnopharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/limnopharma.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/limnopharma.com\/en\/wp-json\/wp\/v2\/comments?post=590"}],"version-history":[{"count":1,"href":"https:\/\/limnopharma.com\/en\/wp-json\/wp\/v2\/posts\/590\/revisions"}],"predecessor-version":[{"id":591,"href":"https:\/\/limnopharma.com\/en\/wp-json\/wp\/v2\/posts\/590\/revisions\/591"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/limnopharma.com\/en\/wp-json\/wp\/v2\/media\/406"}],"wp:attachment":[{"href":"https:\/\/limnopharma.com\/en\/wp-json\/wp\/v2\/media?parent=590"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/limnopharma.com\/en\/wp-json\/wp\/v2\/categories?post=590"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/limnopharma.com\/en\/wp-json\/wp\/v2\/tags?post=590"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}